All lobbying filings

VANTIVE US HEALTHCARE LLC

Lobbying for VANTIVE US HEALTHCARE LLC · Medical Technology Manufacturing

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $550,000.00 expenses · posted Apr 20, 2026

Official filing document

Bills named in this filing 1

HR 4441
Patient Access to Innovative New Technologies Act of 2025

Lobbying activity 4

Medicare/Medicaid

Issues related to ESRD reimbursement Issues related to physician reimbursement for remote patient monitoring Issues related to sepsis device breakthrough designation, including H.R. 4441 - Patient Access to Innovative New Technologies Act

Health Issues

Issues related to ESRD reimbursement Issues related to physician reimbursement for remote patient monitoring

Foreign Relations

Issues related to outstanding reimbursement for dialysis services in Ecuador

Trade (domestic/foreign)

Issues related to tariffs. Issues related to medical technology trade.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.